Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Vannier

Showing results (151-160 of 180) with videos related to

Pageof 18
Sort By:
Blood|February 15, 1995
Neurologic complications after allogeneic marrow transplantation for sickle cell anemiaM C Walters, K M Sullivan, F Bernaudin, et al.
Medical and Pediatric Oncology|August 1, 1997
Therapy-related acute myeloid leukemia with t(8;21) in a child with previous Ewing's sarcomaJ F Lesesve, P Schneider, I Dolgopolov, et al.
Cancer Gene Therapy|June 19, 2010
The soluble fragment of VE-cadherin inhibits angiogenesis by reducing endothelial cell proliferation and tube capillary formationH Li, X Shi, J Liu, et al.
Bone Marrow Transplantation|March 5, 1998
Kinetics of hematopoietic progenitor cell release induced by G-CSF-alone in children with solid tumors and leukemiasJ Kanold, M Berger, P Halle, et al.
Human Gene Therapy|September 30, 2006
Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancerJ-Y Pillé, H Li, E Blot, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2005
Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivoJ-Y Pillé, C Denoyelle, J Varet, et al.
Bone Marrow Transplantation|February 1, 1996
Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP)G Michel, G Leverger, T Leblanc, et al.
Bone Marrow Transplantation|August 1, 1997
Feasibility of a PB CD34+ cell transplantation procedure using standard leukapheresis products in very small childrenM Berger, J Kanold, C Rapatel, et al.
Annals of Hematology|May 6, 2004
Maintenance therapy in childhood acute myeloid leukemiaY Perel, A Auvrignon, T Leblanc, et al.
International Journal of Oncology|December 17, 2013
The small GTPase RhoA regulates the expression and function of the sodium channel Nav1.5 in breast cancer cellsC Dulong, Y J Fang, C Gest, et al.
Pageof 18

Showing results (151-160 of 180) with videos related to

Sort By:
Pageof 18
Blood|February 15, 1995
Neurologic complications after allogeneic marrow transplantation for sickle cell anemiaM C Walters, K M Sullivan, F Bernaudin, et al.
Medical and Pediatric Oncology|August 1, 1997
Therapy-related acute myeloid leukemia with t(8;21) in a child with previous Ewing's sarcomaJ F Lesesve, P Schneider, I Dolgopolov, et al.
Cancer Gene Therapy|June 19, 2010
The soluble fragment of VE-cadherin inhibits angiogenesis by reducing endothelial cell proliferation and tube capillary formationH Li, X Shi, J Liu, et al.
Bone Marrow Transplantation|March 5, 1998
Kinetics of hematopoietic progenitor cell release induced by G-CSF-alone in children with solid tumors and leukemiasJ Kanold, M Berger, P Halle, et al.
Human Gene Therapy|September 30, 2006
Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancerJ-Y Pillé, H Li, E Blot, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2005
Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivoJ-Y Pillé, C Denoyelle, J Varet, et al.
Bone Marrow Transplantation|February 1, 1996
Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP)G Michel, G Leverger, T Leblanc, et al.
Bone Marrow Transplantation|August 1, 1997
Feasibility of a PB CD34+ cell transplantation procedure using standard leukapheresis products in very small childrenM Berger, J Kanold, C Rapatel, et al.
Annals of Hematology|May 6, 2004
Maintenance therapy in childhood acute myeloid leukemiaY Perel, A Auvrignon, T Leblanc, et al.
International Journal of Oncology|December 17, 2013
The small GTPase RhoA regulates the expression and function of the sodium channel Nav1.5 in breast cancer cellsC Dulong, Y J Fang, C Gest, et al.
Pageof 18